Abu Sabah Eradah, Tobin Liam A, Lebreton Francois, McGann Patrick T, Hamidian Mehrad
Australian Institute for Microbiology and Infection, University of Technology Sydney, Ultimo, NSW, Australia.
Multidrug-Resistant Organism Repository and Surveillance Network (MRSN), Bacterial Diseases Branch, CIDR , Walter Reed Army Institute of Research, Silver Spring, MD, USA.
Microb Genom. 2025 Jul;11(7). doi: 10.1099/mgen.0.001450.
We studied the genomic evolution and transmission dynamics of multidrug-resistant ST15 (Institut Pasteur scheme) , examining resistance gene acquisition, clonal diversification, geographic distribution and origin of this high-risk clone. One hundred and fifty-two (=152) ST15 genomes from 18 countries (1997-2024), including 42 isolates from U.S. Military Treatment Facilities and 110 publicly available genomes in GenBank, were analysed. Whole-genome sequencing, assembly and annotation were performed using established bioinformatics pipelines. Phylogenetic analysis based on core-genome SNPs - filtered for recombination with - was combined with mobile element and resistance gene identification. ST15 isolates separated into two main clades with distinct subclades and variable resistance profiles. Homologous recombination drove the diversification of resistance determinants, including multiple alleles. Key resistance genes, such as , were disseminated via known transposons (Tn or Tn), while plasmid exchange, including module acquisitions, also played a role in the spread of . Patristic analysis identified Argentina as the likely origin for the emergence of ST15, aligning with early 1997 isolates. Recombination, transposon-mediated gene transfer and plasmid exchange have been central in driving the evolution and global dissemination of ST15.
我们研究了多重耐药性ST15(巴斯德研究所分型方案)的基因组进化和传播动态,检测了该高风险克隆株的耐药基因获得情况、克隆多样性、地理分布及起源。分析了来自18个国家(1997 - 2024年)的152个ST15基因组,其中包括42株来自美国军事治疗机构的分离株以及GenBank中110个公开可用的基因组。使用既定的生物信息学流程进行全基因组测序、组装和注释。基于核心基因组单核苷酸多态性(SNP)的系统发育分析(经筛选以排除重组影响)与移动元件及耐药基因鉴定相结合。ST15分离株分为两个主要分支,具有不同的亚分支和可变的耐药谱。同源重组推动了耐药决定因素的多样化,包括多个等位基因。关键耐药基因,如某些基因,通过已知转座子(Tn或Tn)传播,而质粒交换,包括某些模块的获得,也在该基因的传播中发挥了作用。祖先分析确定阿根廷可能是ST15出现的起源地,这与1997年初的分离株情况相符。重组、转座子介导的基因转移和质粒交换在推动ST15的进化和全球传播中起到了核心作用。